Dalteparin in emergency patients to prevent admission prior to investigation for venous thromboembolism

American Journal of Emergency Medicine

Volumn 17, Issue 1, 1999, Pages 11-14

  Bauld, Dawn L ^a   Kovacs, Michael J ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Dalteparin; Deep vein thrombosis; Diagnosis; Low molecular weight heparin; Pulmonary embolus

Indexed keywords

DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGE DISTRIBUTION; ARTICLE; COLOR ULTRASOUND FLOWMETRY; COST CONTROL; DRUG SAFETY; FIRST AID; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; LUNG VENTILATION PERFUSION RATIO; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THORAX PAIN; THROMBOEMBOLISM;

EID: 0032956559     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-6757(99)90004-9     Document Type: Article

References (14)

1. Lensing AWA, Prins MH, Davidson BL, et al: Treatment of deep venous thrombosis with low molecular weight heparins: A metaanalysis. Arch Intern Med 1995;155:601-607
2. Siragusa S, Cosmi B, Piovella F, et al: Low molecular weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis. Am J Med 1996;100:269-277
3. Hirsh J, Siragusa S, Cosmi B, et al: Low molecular weight heparins in the treatment of patients with acute venous thromboembolism. Thromb Haemostas 1995;74:360-363
4. Hirsh J. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosis. Haemostasis 1996;4:189-198
5. Leizorovicz A: Comparison of the safety and efficacy of low molecular weight heparins and unfractionated heparin in the initial treatment of deep venous thrombosis: An updated meta-analysis. Drugs 1996;52:30-37
6. The Columbus Investigators: Low molecular weight heparin is an effective and safe treatment for deep-vein thrombosis and pulmonary embolism. New Engl J Med 1997;337:657-662
7. Clagett GP, Reisch JS; Prevention of venous thrombembolism in general surgical patients: Results of a meta-analysis. Ann Surg 1988;208:227-240
8. Kock HJ, Schmit-Neuerburg KP, Hanke J, et al: Thromboprophylaxis with low molecular weight heparin in outpatients with plaster cast immobilization of the leg. Lancet 1995;346:459-461
9. Kujath P, Spannagel U, Habscheid W: Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis 1993;23:20-26
10. Harenburg J, Roebruck P, Heene DL: Subcutaneous low molecular weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients: The heparin study in internal medicine group. Haemostasis 1996;26:127-139
11. Levine M, Gent M, Hirsh J, et al: Acomparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. New Engl J Med 1996;334:677-681
12. Wells PS, Kovacs MJ, Forgie MA, et al: Expanding eligibility for outpatient treatment of deep vein thrombosis and pulmonary embolism with low molecular weight heparin. Arch Intern Med 1998;158:1809-1812
13. Wells PS, Hirsch J, Anderson DR, et al: Accuracy of clinical assessment of deep-vein thrombosis. Lancet 1995;345:1326-1330
14. Wells PS, Brill-Edwards P, Stevens P, et al: A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosis. Circulation 1995;97:2184-2187